Last update:
Weight management news
Mediterranean-inspired diet with added methionine extends healthy lifespan in mice
A plant- and fish-based, low-protein diet paired with small amounts of an amino acid commonly found in eggs, meat and dairy increased healthy lifespan and decreased frailty and fat mass in mice, according to a new USC study ...
50 minutes ago
0
0
Weight‑loss drugs like Ozempic could work for addiction too—and we finally know how
For many people, the thought of a tasty burger or a cold pint of beer conjures a vivid mental image and drives behavior. This link between thinking and doing serves a clear function—it motivates us to get the necessities ...
Jun 22, 2026
0
13
Craving something for dinner? Your mind may be 'tasting' food before you eat it
We've all made that mistake. A quick trip to the supermarket on an empty stomach ends with a trolley full of fatty, sugary treats that seemed impossible to resist at the time.
Jun 22, 2026
0
3
Link between genetics and BMI has become stronger since rise in obesity rates, study finds
People who carry genetic variations linked to obesity are more likely to be heavier now than individuals with the same variants who were born before the recent obesity epidemic. Liam Wright of University College London and ...
Jun 18, 2026
0
11
Can't stick to a diet? Try intermittent fasting for weight loss
Yo-yo dieters who struggle to lose weight and keep it off may achieve better results by following an intermittent fasting diet, rather than traditional calorie counting. An Adelaide University study focusing on the psychological ...
Jun 17, 2026
0
16
Why weight‑loss drugs don't work for some people
Weight-loss jabs are the latest craze for shedding a few pounds. Their effect has been dramatic, with drugs such as Ozempic and Wegovy (semaglutide) causing users to lose up to 15% of their body fat on average.
Jun 17, 2026
0
7
Liver cancer deaths are rapidly increasing. Tackling preventable causes would save lives
Liver cancer is one of the fastest-rising causes of cancer-related deaths in the UK and the third-leading cause of cancer deaths worldwide.
Jun 17, 2026
0
2
Beyond GLP-1s: The next chapter of obesity care
The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.
Jun 17, 2026
0
6
Tirzepatide outperformed semaglutide weight-loss drug results in real world patients, study shows
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have become popular for weight loss, but results vary from person to person and from drug to drug. Venky Soundararajan and colleagues explored the full range of responses ...
Jun 16, 2026
0
13
Simple eating window can rival dietitian advice in pre-diabetes study
A major Australian clinical trial has found that timing when you eat can be just as effective as traditional dietitian-led advice in trying to lower the risk of developing type 2 diabetes.
Jun 16, 2026
0
11
How the rise of weight-loss drugs could reshape food markets in the Global South
A new article published in Globalization and Health warns that the rapid rise of GLP-1 weight-loss drugs in high-income countries could have unintended consequences for food environments in low- and middle-income countries.
Jun 16, 2026
0
4
An economic case for teen weight-loss surgery
Metabolic and bariatric surgery for teens with severe obesity was found to be cost-effective over 10 years, according to a new analysis from Ann & Robert H. Lurie Children's Hospital of Chicago published in JAMA Network Open. ...
Jun 15, 2026
1
3
Tirzepatide GLP-1 medication may be most effective for weight loss
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the University of Georgia.
Jun 15, 2026
0
11
Tirzepatide may change how the body uses energy, trial suggests
Tirzepatide doesn't just help people lose weight; it also activates brown adipose tissue, representing a major milestone in obesity research, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting ...
Jun 15, 2026
0
5
Clinical trials suggest GLP-1s may improve fertility in men with obesity
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve ...
Jun 15, 2026
0
4
Behavioral modifications like goal setting could lead to greater weight loss on tirzepatide
One of the largest real-world studies of people taking GLP-1 medications found women, those without pre-existing conditions such as type 2 diabetes and high blood pressure, and behavioral factors such as previously setting ...
Jun 15, 2026
0
3
Obesity rewrites global heart disease trends, driving rising deaths in midlife and developing nations
Researchers are warning that obesity is reshaping the global cardiovascular disease crisis, as trend data covering 204 countries reveal that heart disease now peaks in people ages 50–54 rather than the elderly and increasingly ...
Jun 15, 2026
0
3
For adults with prediabetes, lifestyle intervention can lower risk of developing multiple chronic conditions
A clinical trial supported by the National Institutes of Health (NIH) found that adults with prediabetes assigned to a lifestyle intervention had a significantly lower risk of developing multiple chronic health conditions ...
Jun 15, 2026
0
2
Visceral fat loss leaves 10-year 'metabolic legacy,' cutting diabetes risk by 28% despite weight regain
Lifestyle-induced loss of visceral fat (and not liver fat, pancreatic fat or subcutaneous fat) may have lasting health benefits years after the end of an intervention, even when body weight is fully regained, according to ...
Jun 14, 2026
0
26
Semaglutide linked to lower bone fracture risk
In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine ...
Jun 14, 2026
0
8
Could a once-a-day pill replace weight loss injections? Phase II oral GLP-1 drug trial shows promising results
For those scared of needles but who need GLP-1 receptor agonists to help manage their weight, there might be some good news. Researchers are testing a new oral, small-molecule GLP-1 receptor agonist called Elecoglipron, which ...
Study finds exercise decreases among people taking GLP-1 medication
Adults with obesity who lost weight with glucagon-like peptide-1 (GLP-1) receptor agonist medications significantly decreased their physical activity, which is essential to protect muscle, according to a study presented at ...
Jun 13, 2026
0
17
Testosterone alone is not a replacement for lifestyle changes in older men at risk of type 2 diabetes, new study shows
Testosterone treatment may improve body composition, glucose metabolism and sexual desire in some older men at high risk of type 2 diabetes (T2D), but the benefits require engagement in a lifestyle program, according to a ...
Jun 13, 2026
0
4
Why drinking alcohol makes you reach for chips and nachos
Have you ever wondered why savory foods like chips, nachos and salted nuts go so well with a beer or glass of wine? And why sometimes you feel an insatiable appetite for junk food while drinking?
Jun 12, 2026
0
9
ADA: Once-weekly cagrilintide + semaglutide promising in type 2 diabetes
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter ...
Jun 12, 2026
0
7
